FDA issued a warning letter to a medical spa for failing to follow requirements that help ensure prescription drugs are safe and come from verified sources. These safeguards protect patients from potentially FDA Warning Letter Breakdown: Sterility Failures, Subpotent GLP 1 Drugs, and a Compounding Pharmacy Operating Without Control BPC 157 Protocols: The Essential Handbook for Regeneration and Health: BPC157 Peptides: Lyman, Dan: 9798309682713: Amazon.com: Books Best BPC 157 Oral Supplements: ProHealth's Triple Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026 Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed FDA issues warning letters to four companies for foreign supplier verification failures Food Safety News